As of April 2024 Abiomed has a market cap of $17.18 Billion. This makes Abiomed the world's 1054th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $17.18 B | 0% |
2023 | $17.18 B | 0% |
2022 | $17.18 B | 5.14% |
2021 | $16.34 B | 11.54% |
2020 | $14.65 B | 90.37% |
2019 | $7.69 B | -47.45% |
2018 | $14.64 B | 76.74% |
2017 | $8.28 B | 69.52% |
2016 | $4.88 B | 27.59% |
2015 | $3.83 B | 145.05% |
2014 | $1.56 B | 47.04% |
2013 | $1.06 B | 103.49% |
2012 | $0.52 B | -26.64% |
2011 | $0.71 B | 95.82% |
2010 | $0.36 B | 11.15% |
2009 | $0.32 B | -45.53% |
2008 | $0.60 B | 18.59% |
2007 | $0.50 B | 34.27% |
2006 | $0.37 B | 54.86% |
2005 | $0.24 B | -28.38% |
2004 | $0.34 B | 129.47% |
2003 | $0.14 B | 93.83% |
2002 | $76.49 M | -76.87% |
2001 | $0.33 B |
On Apr 17th, 2024 the market cap of Abiomed was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $99.10 B | 476.82% | ๐บ๐ธ USA |
Teleflex TFX | $9.76 B | -43.15% | ๐บ๐ธ USA |
AtriCure ATRC | $1.13 B | -93.41% | ๐บ๐ธ USA |